Calendar Vir Biotechnology, Inc.

Equities

VIR

US92764N1028

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
10.68 USD -0.74% Intraday chart for Vir Biotechnology, Inc. -6.32% +6.16%

Chart calendar Vir Biotechnology, Inc.

e5ad88c2db0a96ecb083227053d5d.PBfzOIy0W2XJe_nNXOAK8mME5HerMStpz5hoO677I5c.bCOgUrTOLz3xTMG8PbVtnAxMrTnSdVhcp90AaeqaEqQIWJxbwdIsNIApwQ~476d9cf8753de7bd7424f0f8e5514120

Upcoming events on Vir Biotechnology, Inc.

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-30 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)

Past events on Vir Biotechnology, Inc.

2024-03-13 07:30 am Barclays Global Healthcare Conference
2024-03-10 Leerink Partners Global Biopharma Conference
2024-03-04 02:50 pm TD Cowen Health Care Conference
2024-02-22 04:30 pm Q4 2023 Earnings Call
2024-02-22 04:05 pm Q4 2023 Earnings Release
2024-01-10 06:45 pm JPMorgan Healthcare Conference
2023-11-13 04:45 pm American Association for the Study of Liver Diseases Conference
2023-11-13 03:00 pm American Association for the Study of Liver Diseases Conference - Abstract No 5004
2023-11-13 01:00 pm American Association for the Study of Liver Diseases Conference - Abstract No 48500
2023-11-10 12:00 pm American Association for the Study of Liver Diseases Conference - Poster No: 1326-C
2023-11-10 12:00 pm American Association for the Study of Liver Diseases Conference - Poster No: 1457-C
2023-11-10 12:00 pm American Association for the Study of Liver Diseases Conference - Poster No: 1511-C
2023-11-10 12:00 pm American Association for the Study of Liver Diseases Conference - Poster No: 1480-C
2023-11-10 12:00 pm American Association for the Study of Liver Diseases Conference - Poster No: 1379-C
2023-11-10 12:00 pm American Association for the Study of Liver Diseases Conference - Poster No: 1257-C
2023-11-02 04:30 pm Q3 2023 Earnings Call
2023-11-02 04:05 pm Q3 2023 Earnings Release
2023-10-25 10:00 am H.C. Wainwright NASH Investor Conference
2023-09-12 H.C. Wainwright Global Investment Conference
2023-09-12 08:10 am Morgan Stanley Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
8,09
9,15
-11.6%
76,4
79,3
-3.73%
1 095
906
20.96%
1 616
1 674
-3.48%
86,2
79,7
8.1%

41,4

EBITDA
Million USD
Released
Forecast
Spread
-173
-191
9.36%
-292
-274
-6.42%
427
664
-35.78%
840
1 035
-18.89%
-665
-662
-0.36%

-563

EBIT
Million USD
Released
Forecast
Spread
-178
-196
9.1%
-297
-280
-6.21%
421
275
52.72%
833
903
-7.69%
-684
-697
1.87%

-601

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-175
-193
9.35%
-299
-285
-4.72%
550
463
18.77%
754
777
-2.94%
-628
-660
4.8%

-548

Net income
Million USD
Released
Forecast
Spread
-175
-193
9.26%
-299
-284
-5.1%
529
365
44.82%
516
597
-13.57%
-615
-626
1.76%

-571

EPS
USD
Released
Forecast
Spread
-5,76
-2,77
-107.76%
-2,51
-2,38
-5.29%
3,96
2,74
44.45%
3,83
4,37
-12.32%
-4,59
-4,66
1.5%

-4,20

Announcement Date26/03/2025/02/2124/02/2223/02/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
813
623
30.48%
1 232
811
51.96%
-40,6
211
-119.24%
375
114
227.76%
49,4
134
-63.19%
63,0
50,1
25.67%
3,80
22,4
-83.04%
2,64
8,77
-69.92%
16,8
11,2
50.21%

12,0


9,35


9,63


12,8


40,1

EBITDA
Million USD
Released
Forecast
Spread
573
958
-40.15%
1 015
369
175.39%
-224
12,3
-1920.26%
197
237
-16.98%
-149
142
-204.39%
-138
-146
5.51%
-214


-182
-186
2.11%
-135
-148
8.97%

-123


-141


-144


-131




EBIT
Million USD
Released
Forecast
Spread
572
419
36.52%
1 014
546
85.75%
-225
69,1
-426.15%
195
-52,7
469.78%
-151
-50,0
-200.76%
-143
-124
-15.66%
-215
-177
-21.66%
-187
-185
-1.12%
-139
-166
16.1%

-155


-153


-159


-151




Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
546
450
21.32%
922
588
56.72%
-234
109
-314.43%
218
-37,4
682.25%
-152
-48,9
-210.26%
-143
-144
0.55%
-198
-178
-11.18%
-167
-177
5.97%
-121
-152
20.65%

-141


-138


-140


-136




Net income
Million USD
Released
Forecast
Spread
525
353
48.94%
519
475
9.26%
-76,5
76,4
-200.09%
175
-8,88
2074.08%
-102
-46,0
-120.72%
-141
-115
-22.36%
-195
-168
-16.13%
-163
-167
2.37%
-116
-136
14.5%

-144


-144


-147


-143




EPS
USD
Released
Forecast
Spread
3,92
2,63
49.22%
3,85
3,54
8.76%
-0,58
0,26
-324.37%
1,30
-0,07
2071.19%
-0,76
-0,34
-121.45%
-1,06
-0,86
-23.22%
-1,45
-1,25
-16.34%
-1,22
-1,25
2.03%
-0,86
-1,01
14.5%

-1,07


-1,06


-1,08


-1,04




Announcement Date24/02/2205/05/2209/08/2203/11/2223/02/2304/05/2303/08/2302/11/2322/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise